The drugs giant revealed vaccine sales fell 2 to £2.6 billion in the three months to September 30 as demand waned for its shingles and RSV jabs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results